Samuel N. Hazen, CEO at HCA Healthcare, Inc. (HCA), sold 177,790 shares at $252.44 ($44.7M) on 2021-11-02, disclosed to the SEC on 2021-11-02.
Seasonal sale ($44.7M) by CEO — this insider has traded HCA in November in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $250.46 | 77,790 | $19.5M | 43.6% |
| 2 | $250.96 | 8,581 | $2.2M | 4.8% |
| 3 | $250.96 | 8,581 | $2.2M | 4.8% |
| 4 | $251.84 | 38,260 | $9.6M | 21.6% |
| 5 | $251.84 | 38,260 | $9.6M | 21.6% |
| 6 | $252.44 | 3,159 |
| $797K |
| 1.8% |
| 7 | $252.44 | 3,159 | $797K | 1.8% |
| Total | $251.17 avg | 177,790 | $44.7M | 100% |
| Filing → |
| HCA | SELL | 2018-02-02 | $5.6M | — | Filing → |
| HCA | SELL | 2015-04-17 | $14.4M | — | Filing → |
| HCA | SELL | 2014-12-29 | $13.5M | — | Filing → |